Suchen
Agenus Inc
AGENZur Watchlist hinzufügen
7.850USD
+0.630+8.73%
Handelsschluss 09-18 16:00（ET）
334.53MMarktkapitalisierung
3.80KGV TTM
mehr Informationen über Agenus Inc Unternehmen
Agenus Inc. is a clinical-stage biotechnology company specializing in discovering and developing therapies to activate the body's immune system against cancer and infections. The Company’s pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is immuno-oncology (I-O), and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. Its most advanced antibody candidates are botensilimab (a multifunctional immune cell activator and human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody) and balstilimab (a novel, fully human monoclonal immunoglobulin G4 (IgG4) PD-1 inhibitor). Its pipeline includes several classes of immunotherapies: checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.
Agenus Inc Profil
BörsenkürzelAGEN
Name des UnternehmensAgenus Inc
IPO-datumFeb 04, 2000
CEOArmen (Garo H)
Anzahl der mitarbeiter316
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 04
Addresse3 Forbes Rd
StadtLEXINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl02421-7305
Telefon17816744400
Websitehttps://agenusbio.com/
BörsenkürzelAGEN
IPO-datumFeb 04, 2000
CEOArmen (Garo H)
Führungskräfte von Agenus Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Thomas L. (Tom) Harrison, Ph.D.
Mr. Thomas L. (Tom) Harrison, Ph.D.
Lead Independent Director
Lead Independent Director
47.55K
+17.98%
Mr. Thomas L. (Tom) Harrison, Ph.D.
Mr. Thomas L. (Tom) Harrison, Ph.D.
Lead Independent Director
Lead Independent Director
47.55K
+17.98%
Ms. Christine M. Klaskin
Ms. Christine M. Klaskin
Vice President - Finance
Vice President - Finance
23.48K
+67.22%
Mr. Brian J. Corvese
Mr. Brian J. Corvese
Independent Director
Independent Director
4.60K
--
Mr. Brian J. Corvese
Mr. Brian J. Corvese
Independent Director
Independent Director
4.60K
--
Mr. Marco Tullio Marcucci
Mr. Marco Tullio Marcucci
Director
Director
4.48K
--
Mr. Marco Tullio Marcucci
Mr. Marco Tullio Marcucci
Director
Director
4.48K
--
Wright (Timothy R)
Wright (Timothy R)
Independent Director
Independent Director
2.77K
--
Wright (Timothy R)
Wright (Timothy R)
Independent Director
Independent Director
2.77K
--
Dr. Garo H. Armen, Ph.D.
Dr. Garo H. Armen, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder, Principal Financial Officer
Chairman of the Board, Chief Executive Officer, Co-Founder, Principal Financial Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Thomas L. (Tom) Harrison, Ph.D.
Mr. Thomas L. (Tom) Harrison, Ph.D.
Lead Independent Director
Lead Independent Director
47.55K
+17.98%
Mr. Thomas L. (Tom) Harrison, Ph.D.
Mr. Thomas L. (Tom) Harrison, Ph.D.
Lead Independent Director
Lead Independent Director
47.55K
+17.98%
Ms. Christine M. Klaskin
Ms. Christine M. Klaskin
Vice President - Finance
Vice President - Finance
23.48K
+67.22%
Mr. Brian J. Corvese
Mr. Brian J. Corvese
Independent Director
Independent Director
4.60K
--
Mr. Brian J. Corvese
Mr. Brian J. Corvese
Independent Director
Independent Director
4.60K
--
Mr. Marco Tullio Marcucci
Mr. Marco Tullio Marcucci
Director
Director
4.48K
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Agenus Inc?
Die fünf größten Anteilseigner von Agenus Inc sind: Mr. Thomas L. (Tom) Harrison, Ph.D.
Wie viele Institutionen halten Anteile an Agenus Inc (AGEN)?
Mit Stand vom 2026Q1 halten 275 Institutionen Anteile an Agenus Inc, mit einem Gesamtmarktwert von etwa 10.91M, was 26.27% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -968401.00 gestiegen.
Was ist die größte Einnahmequelle von Agenus Inc?
Am 2026Q1 erzielte das Geschäft mit Non-cash royalty revenue für Agenus Inc den höchsten Umsatz in Höhe von 28.15M, was 81.54% des Gesamtumsatzes entspricht.